Targeting novel sites on reverse transcriptase for HIV treatment and prevention [ 2017 - 2019 ]

Research Grant

Researchers: Prof Gilda Tachedjian (Principal investigator) ,  A/Pr Nicolas Sluis-Cremer ,  Dr David Chalmers ,  Prof Eddy Arnold ,  Prof Philip Thompson

Brief description HIV/AIDS remains a major global threat with 37 million individuals living with HIV in 2014. Antiretroviral drugs have transformed HIV from a death sentence into a chronic disease. Public health organisations recommend dramatic scale up of drugs for HIV treatment and prevention. However, a major threat is that drug options will be exhausted due to drug resistance and toxicity. The major aim of this study is to undertake fundamental studies to advance the development of a new HIV drug class.

Funding Amount $AUD 904,750.57

Funding Scheme Project Grants

Notes Standard Project Grant